{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:28:56Z","timestamp":1793824136751,"version":"4.6.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG6H0281, CMRPD8H0282-3, CMRPD8K0011-3, CMRPD8L0011-3, CMRPD8N0011-2, CMRPD8Q0011"],"award-info":[{"award-number":["CMRPG6H0281, CMRPD8H0282-3, CMRPD8K0011-3, CMRPD8L0011-3, CMRPD8N0011-2, CMRPD8Q0011"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG6H0281, CMRPD8H0282-3, CMRPD8K0011-3, CMRPD8L0011-3, CMRPD8N0011-2, CMRPD8Q0011"],"award-info":[{"award-number":["CMRPG6H0281, CMRPD8H0282-3, CMRPD8K0011-3, CMRPD8L0011-3, CMRPD8N0011-2, CMRPD8Q0011"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG6H0281, CMRPD8H0282-3, CMRPD8K0011-3, CMRPD8L0011-3, CMRPD8N0011-2, CMRPD8Q0011"],"award-info":[{"award-number":["CMRPG6H0281, CMRPD8H0282-3, CMRPD8K0011-3, CMRPD8L0011-3, CMRPD8N0011-2, CMRPD8Q0011"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG6H0281, CMRPD8H0282-3, CMRPD8K0011-3, CMRPD8L0011-3, CMRPD8N0011-2, CMRPD8Q0011"],"award-info":[{"award-number":["CMRPG6H0281, CMRPD8H0282-3, CMRPD8K0011-3, CMRPD8L0011-3, CMRPD8N0011-2, CMRPD8Q0011"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG6H0281, CMRPD8H0282-3, CMRPD8K0011-3, CMRPD8L0011-3, CMRPD8N0011-2, CMRPD8Q0011"],"award-info":[{"award-number":["CMRPG6H0281, CMRPD8H0282-3, CMRPD8K0011-3, CMRPD8L0011-3, CMRPD8N0011-2, CMRPD8Q0011"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["MOST107-2320-B-182-035-MY3 and MOST110-2320-B-182-004-MY3"],"award-info":[{"award-number":["MOST107-2320-B-182-035-MY3 and MOST110-2320-B-182-004-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Polycystic ovary syndrome (PCOS) is a complex disorder characterized by various reproductive, metabolic, and endocrine abnormalities. Hyperandrogenism is a key feature of PCOS that significantly impacts ovarian function. However, its effects on granulosa cells (GCs) function for estrogen production in PCOS remains limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Mouse PCOS-like models were used to investigate the effects of androgen treatments on androgen receptor (AR) downstream gene expression in preantral follicles and primary GCs by qPCR, immunohistochemistry. The expression pattern of AR and FOXL2 was analyzed by single-cell RNA-sequencing analysis, immunohistochemical, and immunofluorescence staining. The AR-FOXL2 interaction was characterized using molecular docking and immunoprecipitation. The functional regulation of the\n                      <jats:italic>CYP19A1<\/jats:italic>\n                      promoter by AR-FOXL2 was further analyzed using chromatin immunoprecipitation and dual-luciferase reporter assay. Effects of AR knockdown and inhibitors on estrogen secretion were evaluated in cultured follicles and GCs. Clinical specimens from PCOS patients with hyperandrogenism were analyzed for estrone and estradiol levels in follicular fluid and gene expression in GCs.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Single-cell RNA sequencing revealed similar expression patterns of AR and FOXL2 across ovarian cell populations. Dihydrotestosterone increased AR protein expression, particularly in preantral follicles, and upregulated both AR and FOXL2 target genes.\n                      <jats:italic>CYP19A1<\/jats:italic>\n                      gene that encodes aromatase was significantly elevated in androgens-treated ovaries, follicles, and GCs. Immunofluorescence and co-immunoprecipitation demonstrated that androgen treatment promotes AR-FOXL2 complex formation, enhancing their binding to the\n                      <jats:italic>CYP19A1<\/jats:italic>\n                      promoter to directly regulate aromatase transcription in GCs. ChIP-PCR confirmed increased AR binding to three AREs in the promoter II region of\n                      <jats:italic>CYP19A1<\/jats:italic>\n                      , with FOXL2 overexpression further enhancing this binding. Elevated estrogen secretion was observed in GCs and cultured follicles, which was attenuated by AR knockdown or inhibition. Clinical samples showed increased estrone, estradiol, and AR, CYP19A1, and FST mRNA expression, with CYP19A1 positively correlating with AR, FOXL2, and estrogen levels.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Hyperandrogenism in PCOS augments estrogen synthesis in GCs by enhancing AR-FOXL2 interactions, which activate\n                      <jats:italic>CYP19A1<\/jats:italic>\n                      gene transcription and thereby increase aromatase expression. This androgen-driven mechanism leads to elevated estrogen levels, offering new insights into the complex pathophysiology of PCOS and strengthening the rationale for targeting the AR-FOXL2-aromatase axis as a therapeutic strategy for ovulation induction in PCOS patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13048-025-01790-4","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T13:20:40Z","timestamp":1756819240000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Hyperandrogenism in polycystic ovary syndrome augments Estrogen synthesis through AR-FOXL2\u2013mediated activation of the aromatase gene in granulosa cells"],"prefix":"10.1186","volume":"18","author":[{"given":"Yi-Ru","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Nung","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Ju","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Min","family":"Hsia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Chung","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Yo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"key":"1790_CR1","doi-asserted-by":"crossref","unstructured":"Amiri M, Hatoum S, Buyalos RP, Sheidaei A, Azziz R. The influence of study quality, age, and geographic factors on Pcos Prevalence - A systematic review and Meta-Analysis. J Clin Endocrinol Metab 2025;110:2082\u20132103.","DOI":"10.1210\/clinem\/dgae917"},{"key":"1790_CR2","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1097\/AOG.0000000000004069","volume":"136","author":"ACOG Practice Bulletin No","year":"2020","unstructured":"ACOG Practice Bulletin No. 194: polycystic ovary syndrome: correction. Obstet Gynecol. 2020;136:638.","journal-title":"Obstet Gynecol"},{"key":"1790_CR3","doi-asserted-by":"publisher","first-page":"111141","DOI":"10.1016\/j.intimp.2023.111141","volume":"125","author":"Y Xiang","year":"2023","unstructured":"Xiang Y, Wang H, Ding H, Xu T, Liu X, Huang Z, Wu H, Ge H. Hyperandrogenism drives ovarian inflammation and pyroptosis: A possible pathogenesis of PCOS follicular dysplasia. Int Immunopharmacol. 2023;125:111141.","journal-title":"Int Immunopharmacol"},{"key":"1790_CR4","first-page":"1","volume":"94","author":"OJ Lucis","year":"1966","unstructured":"Lucis OJ, Hobkirk R, Hollenberg CH, MacDonald SA, Blahey P. Polycystic ovaries associated with congenital adrenal hyperplasia. Can Med Assoc J. 1966;94:1\u20137.","journal-title":"Can Med Assoc J"},{"key":"1790_CR5","first-page":"702","volume":"39","author":"TD Pache","year":"1993","unstructured":"Pache TD, Fauser BC. Polycystic ovaries in female-to-male transsexuals. Clin Endocrinol (Oxf). 1993;39:702\u20133.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1790_CR6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.beem.2018.03.008","volume":"32","author":"KA Walters","year":"2018","unstructured":"Walters KA, Bertoldo MJ, Handelsman DJ. Evidence from animal models on the pathogenesis of PCOS. Best Pract Res Clin Endocrinol Metab. 2018;32:271\u201381.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1790_CR7","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1530\/JOE-19-0530","volume":"245","author":"A Aflatounian","year":"2020","unstructured":"Aflatounian A, Edwards MC, Rodriguez Paris V, Bertoldo MJ, Desai R, Gilchrist RB, Ledger WL, Handelsman DJ, Walters KA. Androgen signaling pathways driving reproductive and metabolic phenotypes in a PCOS mouse model. J Endocrinol. 2020;245:381\u201395.","journal-title":"J Endocrinol"},{"key":"1790_CR8","doi-asserted-by":"publisher","first-page":"e2309429","DOI":"10.1002\/advs.202309429","volume":"11","author":"H Lu","year":"2024","unstructured":"Lu H, Jiang H, Li C, Derisoud E, Zhao A, Eriksson G, Lindgren E, Pui HP, Risal S, Pei Y, et al. Dissecting the impact of maternal androgen exposure on developmental programming through targeting the androgen receptor. Adv Sci (Weinh). 2024;11:e2309429.","journal-title":"Adv Sci (Weinh)"},{"key":"1790_CR9","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.repbio.2013.09.007","volume":"14","author":"EL van Houten","year":"2014","unstructured":"van Houten EL, Visser JA. Mouse models to study polycystic ovary syndrome: a possible link between metabolism and ovarian function? Reprod Biol. 2014;14:32\u201343.","journal-title":"Reprod Biol"},{"key":"1790_CR10","doi-asserted-by":"publisher","first-page":"18319","DOI":"10.1038\/srep18319","volume":"5","author":"MJ Chen","year":"2015","unstructured":"Chen MJ, Chou CH, Chen SU, Yang WS, Yang YS, Ho HN. The effect of androgens on ovarian follicle maturation: dihydrotestosterone suppress FSH-stimulated granulosa cell proliferation by upregulating PPARgamma-dependent PTEN expression. Sci Rep. 2015;5:18319.","journal-title":"Sci Rep"},{"key":"1790_CR11","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1053\/beem.2002.0203","volume":"16","author":"S Franks","year":"2002","unstructured":"Franks S. Adult polycystic ovary syndrome begins in childhood. Best Pract Res Clin Endocrinol Metab. 2002;16:263\u201372.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1790_CR12","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1210\/en.2017-03218","volume":"159","author":"GE Ryan","year":"2018","unstructured":"Ryan GE, Malik S, Mellon PL. Antiandrogen treatment ameliorates reproductive and metabolic phenotypes in the Letrozole-Induced mouse model of PCOS. Endocrinology. 2018;159:1734\u201347.","journal-title":"Endocrinology"},{"key":"1790_CR13","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3109\/09513590.2012.754876","volume":"29","author":"R Paradisi","year":"2013","unstructured":"Paradisi R, Fabbri R, Battaglia C, Venturoli S. Ovulatory effects of Flutamide in the polycystic ovary syndrome. Gynecol Endocrinol. 2013;29:391\u20135.","journal-title":"Gynecol Endocrinol"},{"key":"1790_CR14","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1136\/jcp-2023-208827","volume":"76","author":"A Mubeen","year":"2023","unstructured":"Mubeen A, Parra-Herran C. FOXL2: a gene central to ovarian function. J Clin Pathol. 2023;76:798\u2013801.","journal-title":"J Clin Pathol"},{"key":"1790_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.mce.2011.06.019","volume":"356","author":"S Caburet","year":"2012","unstructured":"Caburet S, Georges A, L\u2019Hote D, Todeschini AL, Benayoun BA, Veitia RA. The transcription factor FOXL2: at the crossroads of ovarian physiology and pathology. Mol Cell Endocrinol. 2012;356:55\u201364.","journal-title":"Mol Cell Endocrinol"},{"key":"1790_CR16","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1056\/NEJMoa0902542","volume":"360","author":"SP Shah","year":"2009","unstructured":"Shah SP, Kobel M, Senz J, Morin RD, Clarke BA, Wiegand KC, Leung G, Zayed A, Mehl E, Kalloger SE, et al. Mutation of FOXL2 in granulosa-cell tumors of the ovary. N Engl J Med. 2009;360:2719\u201329.","journal-title":"N Engl J Med"},{"key":"1790_CR17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1210\/er.2011-0014","volume":"33","author":"S Jamieson","year":"2012","unstructured":"Jamieson S, Fuller PJ. Molecular pathogenesis of granulosa cell tumors of the ovary. Endocr Rev. 2012;33:109\u201344.","journal-title":"Endocr Rev"},{"key":"1790_CR18","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1242\/dev.00969","volume":"131","author":"D Schmidt","year":"2004","unstructured":"Schmidt D, Ovitt CE, Anlag K, Fehsenfeld S, Gredsted L, Treier AC, Treier M. The murine winged-helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance. Development. 2004;131:933\u201342.","journal-title":"Development"},{"key":"1790_CR19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.biocel.2016.01.003","volume":"72","author":"DTH Leung","year":"2016","unstructured":"Leung DTH, Fuller PJ, Chu S. Impact of FOXL2 mutations on signaling in ovarian granulosa cell tumors. Int J Biochem Cell Biol. 2016;72:51\u20134.","journal-title":"Int J Biochem Cell Biol"},{"key":"1790_CR20","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.cell.2009.11.021","volume":"139","author":"NH Uhlenhaut","year":"2009","unstructured":"Uhlenhaut NH, Jakob S, Anlag K, Eisenberger T, Sekido R, Kress J, Treier AC, Klugmann C, Klasen C, Holter NI, et al. Somatic sex reprogramming of adult ovaries to testes by FOXL2 ablation. Cell. 2009;139:1130\u201342.","journal-title":"Cell"},{"key":"1790_CR21","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1093\/biolre\/ioaa146","volume":"103","author":"B Nicol","year":"2020","unstructured":"Nicol B, Rodriguez K, Yao HH. Aberrant and constitutive expression of FOXL2 impairs ovarian development and functions in mice. Biol Reprod. 2020;103:966\u201377.","journal-title":"Biol Reprod"},{"key":"1790_CR22","doi-asserted-by":"crossref","unstructured":"Baddela VS, Michaelis M, Tao X, Koczan D, Vanselow J. ERK1\/2-SOX9\/FOXL2 axis regulates ovarian steroidogenesis and favors the follicular-luteal transition. Life Sci Alliance 2023;6:e202302100.","DOI":"10.26508\/lsa.202302100"},{"key":"1790_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jsbmb.2017.01.009","volume":"168","author":"S Patel","year":"2017","unstructured":"Patel S. Disruption of aromatase homeostasis as the cause of a multiplicity of ailments: A comprehensive review. J Steroid Biochem Mol Biol. 2017;168:19\u201325.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1790_CR24","unstructured":"Middlemas DS, Ousterhout J. Female Hormone Regulation. Brody\u2019s Human Pharmacology-E-Book: Brody\u2019s Human Pharmacology-E-Book 2024:446."},{"key":"1790_CR25","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1146\/annurev.physiol.64.081601.142703","volume":"64","author":"ER Simpson","year":"2002","unstructured":"Simpson ER, Clyne C, Rubin G, Boon WC, Robertson K, Britt K, Speed C, Jones M. Aromatase\u2013a brief overview. Annu Rev Physiol. 2002;64:93\u2013127.","journal-title":"Annu Rev Physiol"},{"key":"1790_CR26","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/bs.pmbts.2016.10.002","volume":"144","author":"PR Manna","year":"2016","unstructured":"Manna PR, Molehin D, Ahmed AU. Dysregulation of aromatase in breast, endometrial, and ovarian cancers: an overview of therapeutic strategies. Prog Mol Biol Transl Sci. 2016;144:487\u2013537.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"1790_CR27","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1210\/jc.2009-1908","volume":"95","author":"E Stener-Victorin","year":"2010","unstructured":"Stener-Victorin E, Holm G, Labrie F, Nilsson L, Janson PO, Ohlsson C. Are there any sensitive and specific sex steroid markers for polycystic ovary syndrome? J Clin Endocrinol Metab. 2010;95:810\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"1790_CR28","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.1007\/s43032-022-00985-0","volume":"29","author":"J Ge","year":"2022","unstructured":"Ge J, Yang N, Zhang X, Li M, Zhang W, He J, Zhu H, Cheng X, Shen S, Ge W. Steroid hormone profiling in hyperandrogenism and Non-hyperandrogenism women with polycystic ovary syndrome. Reprod Sci. 2022;29:3449\u201358.","journal-title":"Reprod Sci"},{"key":"1790_CR29","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3109\/09513590.2015.1134478","volume":"32","author":"I Gozukara","year":"2016","unstructured":"Gozukara I, Dokuyucu R, Ozgur T, Ozcan O, Pinar N, Kurt RK, Kucur SK, Dolapcioglu K. Histopathologic and metabolic effect of ursodeoxycholic acid treatment on PCOS rat model. Gynecol Endocrinol. 2016;32:492\u20137.","journal-title":"Gynecol Endocrinol"},{"key":"1790_CR30","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1159\/000494300","volume":"27","author":"A Karateke","year":"2018","unstructured":"Karateke A, Dokuyucu R, Dogan H, Ozgur T, Tas ZA, Tutuk O, Agturk G, Tumer C. Investigation of therapeutic effects of erdosteine on polycystic ovary syndrome in a rat model. Med Princ Pract. 2018;27:515\u201322.","journal-title":"Med Princ Pract"},{"key":"1790_CR31","doi-asserted-by":"crossref","unstructured":"Heidarzadehpilehrood R, Pirhoushiaran M, Abdollahzadeh R, Binti Osman M, Sakinah M, Nordin N, Abdul Hamid H. A review on CYP11A1, CYP17A1, and CYP19A1 polymorphism studies: candidate susceptibility genes for polycystic ovary syndrome (PCOS) and infertility. Genes (Basel) 2022;13:302.","DOI":"10.3390\/genes13020302"},{"key":"1790_CR32","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.fertnstert.2008.07.016","volume":"92","author":"M Pusalkar","year":"2009","unstructured":"Pusalkar M, Meherji P, Gokral J, Chinnaraj S, Maitra A. CYP11A1 and CYP17 promoter polymorphisms associate with hyperandrogenemia in polycystic ovary syndrome. Fertil Steril. 2009;92:653\u20139.","journal-title":"Fertil Steril"},{"key":"1790_CR33","first-page":"4103","volume":"81","author":"L Ibanez","year":"1996","unstructured":"Ibanez L, Hall JE, Potau N, Carrascosa A, Prat N, Taylor AE. Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing. J Clin Endocrinol Metab. 1996;81:4103\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"1790_CR34","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/S0015-0282(02)04346-7","volume":"78","author":"A la Marca","year":"2002","unstructured":"la Marca A, Morgante G, Palumbo M, Cianci A, Petraglia F, De Leo V. Insulin-lowering treatment reduces aromatase activity in response to follicle-stimulating hormone in women with polycystic ovary syndrome. Fertil Steril. 2002;78:1234\u20139.","journal-title":"Fertil Steril"},{"key":"1790_CR35","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/oxfordjournals.humrep.a135980","volume":"10","author":"AM Suikkari","year":"1995","unstructured":"Suikkari AM, MacLachlan V, Montalto J, Calderon I, Healy DL, McLachlan RI. Ultrasonographic appearance of polycystic ovaries is associated with exaggerated ovarian androgen and oestradiol responses to gonadotrophin-releasing hormone agonist in women undergoing assisted reproduction treatment. Hum Reprod. 1995;10:513\u20139.","journal-title":"Hum Reprod"},{"key":"1790_CR36","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.jcyt.2018.09.005","volume":"20","author":"Z Kalhori","year":"2018","unstructured":"Kalhori Z, Azadbakht M, Soleimani Mehranjani M, Shariatzadeh MA. Improvement of the folliculogenesis by transplantation of bone marrow mesenchymal stromal cells in mice with induced polycystic ovary syndrome. Cytotherapy. 2018;20:1445\u201358.","journal-title":"Cytotherapy"},{"key":"1790_CR37","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1210\/en.2011-1754","volume":"153","author":"EL van Houten","year":"2012","unstructured":"van Houten EL, Kramer P, McLuskey A, Karels B, Themmen AP, Visser JA. Reproductive and metabolic phenotype of a mouse model of PCOS. Endocrinology. 2012;153:2861\u20139.","journal-title":"Endocrinology"},{"key":"1790_CR38","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1210\/en.2014-1196","volume":"155","author":"AS Caldwell","year":"2014","unstructured":"Caldwell AS, Middleton LJ, Jimenez M, Desai R, McMahon AC, Allan CM, Handelsman DJ, Walters KA. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models. Endocrinology. 2014;155:3146\u201359.","journal-title":"Endocrinology"},{"key":"1790_CR39","doi-asserted-by":"publisher","first-page":"111028","DOI":"10.1016\/j.isci.2024.111028","volume":"27","author":"M Luo","year":"2024","unstructured":"Luo M, Yang X, Zhou M, Zhang J, Yu B, Lian H, Ye J. Integrated single-cell and Spatial transcriptomics reveal microenvironment disruptions by androgen in mouse ovary. iScience. 2024;27:111028.","journal-title":"iScience"},{"key":"1790_CR40","first-page":"134","volume":"158","author":"K Hardy","year":"2017","unstructured":"Hardy K, Fenwick M, Mora J, Laird M, Thomson K, Franks S. Onset and heterogeneity of responsiveness to FSH in mouse preantral follicles in culture. Endocrinology. 2017;158:134\u201347.","journal-title":"Endocrinology"},{"key":"1790_CR41","doi-asserted-by":"publisher","first-page":"W365","DOI":"10.1093\/nar\/gkx407","volume":"45","author":"Y Yan","year":"2017","unstructured":"Yan Y, Zhang D, Zhou P, Li B, Huang SY. HDOCK: a web server for protein-protein and protein-DNA\/RNA Docking based on a hybrid strategy. Nucleic Acids Res. 2017;45:W365\u201373.","journal-title":"Nucleic Acids Res"},{"key":"1790_CR42","doi-asserted-by":"publisher","first-page":"e1009483","DOI":"10.1371\/journal.pgen.1009483","volume":"17","author":"S Roy","year":"2021","unstructured":"Roy S, Huang B, Sinha N, Wang J, Sen A. Androgens regulate ovarian gene expression by balancing Ezh2-Jmjd3 mediated H3K27me3 dynamics. PLoS Genet. 2021;17:e1009483.","journal-title":"PLoS Genet"},{"key":"1790_CR43","doi-asserted-by":"publisher","first-page":"12435","DOI":"10.1073\/pnas.0603006103","volume":"103","author":"TN Parakh","year":"2006","unstructured":"Parakh TN, Hernandez JA, Grammer JC, Weck J, Hunzicker-Dunn M, Zeleznik AJ, Nilson JH. Follicle-stimulating hormone\/camp regulation of aromatase gene expression requires beta-catenin. Proc Natl Acad Sci U S A. 2006;103:12435\u201340.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1790_CR44","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.fertnstert.2022.09.324","volume":"119","author":"DA Dumesic","year":"2023","unstructured":"Dumesic DA, Winnett C, Lu G, Grogan TR, Abbott DH, Naik R, Chazenbalk GD. Randomized clinical trial: effect of low-dose Flutamide on abdominal adipogenic function in normal-weight women with polycystic ovary syndrome. Fertil Steril. 2023;119:116\u201326.","journal-title":"Fertil Steril"},{"key":"1790_CR45","first-page":"374","volume":"48","author":"N Kim","year":"2021","unstructured":"Kim N, Chun S. Association between the serum estrone-to-estradiol ratio and parameters related to glucose metabolism and insulin resistance in women with polycystic ovary syndrome. Clin Exp Reprod Med. 2021;48:374\u20139.","journal-title":"Clin Exp Reprod Med"},{"key":"1790_CR46","doi-asserted-by":"crossref","unstructured":"Xu XL, Deng SL, Lian ZX, Yu K. Estrogen receptors in polycystic ovary syndrome. Cells 2021;10:459.","DOI":"10.3390\/cells10020459"},{"key":"1790_CR47","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1095\/biolreprod35.3.647","volume":"35","author":"JR Brawer","year":"1986","unstructured":"Brawer JR, Munoz M, Farookhi R. Development of the polycystic ovarian condition (PCO) in the estradiol valerate-treated rat. Biol Reprod. 1986;35:647\u201355.","journal-title":"Biol Reprod"},{"key":"1790_CR48","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1095\/biolreprod.107.063974","volume":"78","author":"R Sotomayor-Zarate","year":"2008","unstructured":"Sotomayor-Zarate R, Dorfman M, Paredes A, Lara HE. Neonatal exposure to estradiol valerate programs ovarian sympathetic innervation and follicular development in the adult rat. Biol Reprod. 2008;78:673\u201380.","journal-title":"Biol Reprod"},{"key":"1790_CR49","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/09513590.2019.1633296","volume":"36","author":"S Chun","year":"2020","unstructured":"Chun S. Relationship between early follicular serum estrone level and other hormonal or ultrasonographic parameters in women with polycystic ovary syndrome. Gynecol Endocrinol. 2020;36:143\u20137.","journal-title":"Gynecol Endocrinol"},{"key":"1790_CR50","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12958-021-00749-6","volume":"19","author":"L Yu","year":"2021","unstructured":"Yu L, Liu M, Wang Z, Liu T, Liu S, Wang B, Pan B, Dong X, Guo W. Correlation between steroid levels in follicular fluid and hormone synthesis related substances in its exosomes and embryo quality in patients with polycystic ovary syndrome. Reprod Biol Endocrinol. 2021;19:74.","journal-title":"Reprod Biol Endocrinol"},{"key":"1790_CR51","doi-asserted-by":"publisher","first-page":"105806","DOI":"10.1016\/j.jsbmb.2020.105806","volume":"206","author":"Z Yang","year":"2021","unstructured":"Yang Z, Zhou W, Zhou C, Zhou Y, Liu X, Ding G, Hu Y, Pan J, Sheng J, Jin L, Huang H. Steroid metabolome profiling of follicular fluid in normo- and hyperandrogenic women with polycystic ovary syndrome. J Steroid Biochem Mol Biol. 2021;206:105806.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1790_CR52","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.tjog.2024.01.002","volume":"63","author":"ST Yang","year":"2024","unstructured":"Yang ST, Chang WH, Wang PH. Function of the granulosa cells in women with polycystic ovary syndrome. Taiwan J Obstet Gynecol. 2024;63:141\u20133.","journal-title":"Taiwan J Obstet Gynecol"},{"key":"1790_CR53","doi-asserted-by":"publisher","first-page":"8993","DOI":"10.1038\/s41598-020-65890-5","volume":"10","author":"XY Gao","year":"2020","unstructured":"Gao XY, Liu Y, Lv Y, Huang T, Lu G, Liu HB, Zhao SG. Role of androgen receptor for reconsidering the true polycystic ovarian morphology in PCOS. Sci Rep. 2020;10:8993.","journal-title":"Sci Rep"},{"key":"1790_CR54","doi-asserted-by":"publisher","first-page":"10272","DOI":"10.1038\/s41598-017-09880-0","volume":"7","author":"JJ Lim","year":"2017","unstructured":"Lim JJ, Lima PDA, Salehi R, Lee DR, Tsang BK. Regulation of androgen receptor signaling by ubiquitination during folliculogenesis and its possible dysregulation in polycystic ovarian syndrome. Sci Rep. 2017;7:10272.","journal-title":"Sci Rep"},{"key":"1790_CR55","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13048-022-01087-w","volume":"16","author":"X Zeng","year":"2023","unstructured":"Zeng X, Zhong Q, Li M, Liu Y, Long S, Xie Y, Mo Z. Androgen increases Klotho expression via the androgen receptor-mediated pathway to induce GCs apoptosis. J Ovarian Res. 2023;16:10.","journal-title":"J Ovarian Res"},{"key":"1790_CR56","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1210\/en.2014-1887","volume":"156","author":"AS Caldwell","year":"2015","unstructured":"Caldwell AS, Eid S, Kay CR, Jimenez M, McMahon AC, Desai R, Allan CM, Smith JT, Handelsman DJ, Walters KA. Haplosufficient genomic androgen receptor signaling is adequate to protect female mice from induction of polycystic ovary syndrome features by prenatal hyperandrogenization. Endocrinology. 2015;156:1441\u201352.","journal-title":"Endocrinology"},{"key":"1790_CR57","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.mce.2013.02.004","volume":"369","author":"T Yazawa","year":"2013","unstructured":"Yazawa T, Kawabe S, Kanno M, Mizutani T, Imamichi Y, Ju Y, Matsumura T, Yamazaki Y, Usami Y, Kuribayashi M, et al. Androgen\/androgen receptor pathway regulates expression of the genes for cyclooxygenase-2 and Amphiregulin in periovulatory granulosa cells. Mol Cell Endocrinol. 2013;369:42\u201351.","journal-title":"Mol Cell Endocrinol"},{"key":"1790_CR58","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13048-019-0505-5","volume":"12","author":"Y Fujibe","year":"2019","unstructured":"Fujibe Y, Baba T, Nagao S, Adachi S, Ikeda K, Morishita M, Kuno Y, Suzuki M, Mizuuchi M, Honnma H, et al. Androgen potentiates the expression of FSH receptor and supports preantral follicle development in mice. J Ovarian Res. 2019;12:31.","journal-title":"J Ovarian Res"},{"key":"1790_CR59","doi-asserted-by":"crossref","unstructured":"Sucquart IE, Coyle C, Rodriguez Paris V, Prescott M, Glendining KA, Potapov K, Begg DP, Gilchrist RB, Walters KA, Campbell RE. Investigating GABA Neuron-Specific androgen receptor knockout in two hyperandrogenic models of PCOS. Endocrinology 2024;165:bqae060.","DOI":"10.1210\/endocr\/bqae060"},{"key":"1790_CR60","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1002\/mrd.22343","volume":"81","author":"L Scotti","year":"2014","unstructured":"Scotti L, Parborell F, Irusta G, De Zuniga I, Bisioli C, Pettorossi H, Tesone M, Abramovich D. Platelet-derived growth factor BB and DD and angiopoietin1 are altered in follicular fluid from polycystic ovary syndrome patients. Mol Reprod Dev. 2014;81:748\u201356.","journal-title":"Mol Reprod Dev"},{"key":"1790_CR61","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.rbmo.2016.03.003","volume":"32","author":"V Kanamarlapudi","year":"2016","unstructured":"Kanamarlapudi V, Gordon UD, Lopez Bernal A. Luteinizing hormone\/chorionic gonadotrophin receptor overexpressed in granulosa cells from polycystic ovary syndrome ovaries is functionally active. Reprod Biomed Online. 2016;32:635\u201341.","journal-title":"Reprod Biomed Online"},{"key":"1790_CR62","doi-asserted-by":"publisher","first-page":"4456","DOI":"10.1210\/jc.2008-1231","volume":"93","author":"S Catteau-Jonard","year":"2008","unstructured":"Catteau-Jonard S, Jamin SP, Leclerc A, Gonzales J, Dewailly D, di Clemente N. Anti-Mullerian hormone, its receptor, FSH receptor, and androgen receptor genes are overexpressed by granulosa cells from stimulated follicles in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2008;93:4456\u201361.","journal-title":"J Clin Endocrinol Metab"},{"key":"1790_CR63","doi-asserted-by":"publisher","first-page":"e14389","DOI":"10.1371\/journal.pone.0014389","volume":"5","author":"NI Fleming","year":"2010","unstructured":"Fleming NI, Knower KC, Lazarus KA, Fuller PJ, Simpson ER, Clyne CD. Aromatase is a direct target of FOXL2: C134W in granulosa cell tumors via a single highly conserved binding site in the ovarian specific promoter. PLoS ONE. 2010;5:e14389.","journal-title":"PLoS ONE"},{"key":"1790_CR64","doi-asserted-by":"publisher","first-page":"887","DOI":"10.5114\/aoms.2019.86060","volume":"15","author":"E Hosseini","year":"2019","unstructured":"Hosseini E, Shahhoseini M, Afsharian P, Karimian L, Ashrafi M, Mehraein F, Afatoonian R. Role of epigenetic modifications in the aberrant CYP19A1 gene expression in polycystic ovary syndrome. Arch Med Sci. 2019;15:887\u201395.","journal-title":"Arch Med Sci"},{"key":"1790_CR65","doi-asserted-by":"publisher","first-page":"4558","DOI":"10.1242\/dev.112672","volume":"143","author":"ML Golson","year":"2016","unstructured":"Golson ML, Kaestner KH. Fox transcription factors: from development to disease. Development. 2016;143:4558\u201370.","journal-title":"Development"},{"key":"1790_CR66","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1196\/annals.1336.009","volume":"1061","author":"X Yu","year":"2005","unstructured":"Yu X, Gupta A, Wang Y, Suzuki K, Mirosevich J, Orgebin-Crist MC, Matusik RJ. Foxa1 and Foxa2 interact with the androgen receptor to regulate prostate and epididymal genes differentially. Ann N Y Acad Sci. 2005;1061:77\u201393.","journal-title":"Ann N Y Acad Sci"},{"key":"1790_CR67","doi-asserted-by":"crossref","unstructured":"Georges A, L\u2019Hote D, Todeschini AL, Auguste A, Legois B, Zider A, Veitia RA. The transcription factor FOXL2 mobilizes Estrogen signaling to maintain the identity of ovarian granulosa cells. Elife 2014;3:e04207.","DOI":"10.7554\/eLife.04207"},{"key":"1790_CR68","doi-asserted-by":"publisher","first-page":"eadl0788","DOI":"10.1126\/sciadv.adl0788","volume":"10","author":"R Migale","year":"2024","unstructured":"Migale R, Neumann M, Mitter R, Rafiee MR, Wood S, Olsen J, Lovell-Badge R. FOXL2 interaction with different binding partners regulates the dynamics of ovarian development. Sci Adv. 2024;10:eadl0788.","journal-title":"Sci Adv"},{"key":"1790_CR69","doi-asserted-by":"publisher","first-page":"e0141062","DOI":"10.1371\/journal.pone.0141062","volume":"10","author":"N Qin","year":"2015","unstructured":"Qin N, Fan XC, Xu XX, Tyasi TL, Li SJ, Zhang YY, Wei ML, Xu RF. Cooperative effects of FOXL2 with the members of TGF-beta superfamily on FSH receptor mRNA expression and granulosa cell proliferation from Hen prehierarchical follicles. PLoS ONE. 2015;10:e0141062.","journal-title":"PLoS ONE"},{"key":"1790_CR70","first-page":"170","volume":"5","author":"RS Mandelbaum","year":"2024","unstructured":"Mandelbaum RS, Agarwal R, Melville S, Violette CJ, Winer S, Shoupe D, Matsuo K, Paulson RJ, Quinn MM. A comparison of letrozole regimens for ovulation induction in women with polycystic ovary syndrome. F S Rep. 2024;5:170\u20135.","journal-title":"F S Rep"},{"key":"1790_CR71","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4103\/0974-1208.117166","volume":"6","author":"S Kar","year":"2013","unstructured":"Kar S. Current evidence supporting letrozole for ovulation induction. J Hum Reprod Sci. 2013;6:93\u20138.","journal-title":"J Hum Reprod Sci"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01790-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-025-01790-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01790-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:32:43Z","timestamp":1781609563000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13048-025-01790-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1790"],"URL":"https:\/\/doi.org\/10.1186\/s13048-025-01790-4","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"assertion":[{"value":"27 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval of the experiments involved in this study has been acquired from the Ethics Committee of Chang Gung Memorial Hospital (No. CMRPD8L0011-3). The use of samples from human in this study was obtained from the Institutional Review Board of Chang Gung Memorial Hospital (IRB approval number: 202301022B0) All experiments on the animals were designed according to the Guide for the Care and Use of Laboratory Animals (No. 2021061801). All animal investigations were conducted at Institutional Animal Care and Use Committee of Chang Gung Memorial Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors confirm the consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"200"}}